Guidewire Use in Nasotracheal Intubation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05937516 |
Recruitment Status :
Completed
First Posted : July 10, 2023
Last Update Posted : July 10, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Epistaxis Nosebleed Pharyngeal Bleeding | Device: Nasotracheal intubation with conventionally Device: Nasotracheal intubation with angled ETT using guidewire | Not Applicable |
Nasotracheal intubation (NTI) is a frequently used airway management method in pedodontic dental treatments performed under general anesthesia. However, nasopharyngeal trauma and associated bleeding are common during conventional NTI. In this study, the investigators aimed to examine the effect of angling the end of the endotracheal tube (ETT) by placing a guide wire inside the ETT on nasopharyngeal bleeding.
The patients included in the study were randomized into two groups. In the control group (Group C), NTI will be done conventionally. In the study group (Group S), a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 90 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Masking Description: | After intubation was completed, bleeding was evaluated by the other investigator who did not know the patient's group. |
Primary Purpose: | Diagnostic |
Official Title: | Guidewire Use for Nasopharyngeal Passage in Pediatric Nasotracheal Intubation: A Randomized Prospective Study |
Actual Study Start Date : | March 15, 2023 |
Actual Primary Completion Date : | April 20, 2023 |
Actual Study Completion Date : | April 20, 2023 |
Arm | Intervention/treatment |
---|---|
Sham Comparator: Control Group
Nasotracheal intubation will be applied conventionally to patients in this group.
|
Device: Nasotracheal intubation with conventionally
Nasotracheal intubation will be applied conventionally to patients in this group. |
Active Comparator: Study Group
In the study group (Group S), a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method.
|
Device: Nasotracheal intubation with angled ETT using guidewire
a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method. |
- Presence of blood in oropharynx or on the endotracheal tube [ Time Frame: In the first minute after intubation ]The presence of blood in the oropharynx or endotracheal tube will be defined by assessing it on a scale. (0 = no blood, 2 = mild, that is, dye-like blood on the endotracheal tube, 3 = severe, that is, obvious blood in the oropharynx).
- Presence of blood in oropharynx or on the endotracheal tube [ Time Frame: In the fifth minute after intubation ]The presence of blood in the oropharynx or endotracheal tube will be defined by assessing it on a scale. (0 = no blood, 2 = mild, that is, dye-like blood on the endotracheal tube, 3 = severe, that is, obvious blood in the oropharynx).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 2-12 years old
- American Society of Anesthesiologists I-III
- Patients with elective dental surgery
- Patients whose parents have accepted informed consent forms
- Patients without previous nasopharyngeal anomalies
- Patients without previous nasopharyngeal surgeries
- Patients without upper airway infections
Exclusion Criteria:
- Under 2 or over 12 years old
- Emergency surgeries
- Patients whose parents have not accepted informed consent forms
- Patients with previous nasopharyngeal anomalies
- Patients with previous nasopharyngeal surgeries
- Patients with upper airway infections
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05937516
Turkey | |
Bezmialem Vakif University, Faculty of Medicine | |
Fatih, Istanbul, Turkey, 34093 |
Principal Investigator: | asim esen, Asst Prof | Bezmialem Vakif University, Faculty of Medicine |
Responsible Party: | Asım Esen, Assistant Professor ASIM ESEN, Bezmialem Vakif University |
ClinicalTrials.gov Identifier: | NCT05937516 |
Other Study ID Numbers: |
a.esen001 |
First Posted: | July 10, 2023 Key Record Dates |
Last Update Posted: | July 10, 2023 |
Last Verified: | July 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Airway management Intubation complication Nasotracheal intubation Nasal bleeding |
Epistaxis Hemorrhage Pathologic Processes Nose Diseases |
Respiratory Tract Diseases Otorhinolaryngologic Diseases Signs and Symptoms, Respiratory |